JPRN-UMIN000007993已完成未知
Change of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B - Change of HBsAg during long-term NA therapy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •HCV co-infection HIV co-infection
研究者
相似试验
已完成
不适用
Correlation of serum hepatitis B surface antigen level with response to entecavir in naive patients with chronic hepatitis BCertain infectious and parasitic diseasesKCT0000087Ajou University101
进行中（未招募）
1 期
ong-term persistence of immunity to hepatitis B in adults vaccinated with GlaxoSmithKline (GSK) Biologicals’ hepatitis B vaccine (HBV), Engerix™-B.Healthy volunteers (immunisation against infection caused by all known subtypes of hepatitis B virus).MedDRA version: 19.0Level: PTClassification code 10019731Term: Hepatitis BSystem Organ Class: 10021881 - Infections and infestationsEUCTR2015-004099-31-BEGlaxosmithkline Biologicals100
已完成
4 期
Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ MothersHepatitis BNCT00240500GlaxoSmithKline109
已完成
3 期
Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 YrsHepatitis BNCT00343915GlaxoSmithKline267
进行中（未招募）
不适用
An open-label, phase IV, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immunogenicity and safety study of a single dose hepatitis B (Engerix™-B Kinder) vaccine challenge in adolescents aged 12-13 years, previously primed and boosted in the first two years of life with four doses of GSK Biologicals’ DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine.Hepatitis BEUCTR2013-002821-41-DEGlaxoSmithKline Biologicals